Skip to main content
SpringerLink
Log in

Oral Medical Therapy

  • Chapter
Gallstone Disease and its Management

Abstract

Until recently, cholecystectomy was the only treatment for gallstone disease. During the past 15 years, the discovery that gallstone patients have gallbladder bile that is supersaturated with cholesterol has led to the introduction of bile acid therapy aimed at desaturating bile and thus causing gallstone dissolution.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 16.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Dissolving hopes for gallstone dissolution (Editorial) (1981). Lancet, 2, 905–906

    Google Scholar 

  2. Isselbacher, K. J. (1981). Chenodiol for gallstones: dissolution or disillusion? (Editorial). Ann. Intern. Med., 95, 377–379

    PubMed  CAS  Google Scholar 

  3. Schoenfield, L. J., Lachin, J. M., The Steering Committee and the National Cooperative Gallstone Study Group (1981). Chenodiol (chenodeoxycholic acid) for dissolution of gallstones: the National Cooperative Gallstone Study. Ann. Intern. Med., 95, 257–282

    CAS  Google Scholar 

  4. Mok, H. Y. I., Bell, G. D. and Dowling, R. H. (1974). Effect of differing doses of chenodeoxycholic acid of bile lipid composition and frequency of side effects in patients with gallstones. Lancet, 2, 253–257

    Article  PubMed  CAS  Google Scholar 

  5. Thistle, J. L., Hofmann, A. F., Yu, P. Y. S. et al (1977). Effect of varying doses of chenodeoxycholic acid on bile lipid and biliary bile acid composition in gallstone patients: a dose-response study. Dig. Dis., 22, 1–6

    Article  CAS  Google Scholar 

  6. Ruppin, D. C. and Dowling, R. H. (1982). Is recurrence inevitable after gallstone dissolution by bile acid treatment? Lancet, 1, 181–185

    Article  PubMed  CAS  Google Scholar 

  7. Danzinger, R. G., Hofmann, A. F., Schoenfield, L. J. and Thistle, J. L. (1972). Dissolution of cholesterol gallstones by chenodeoxycholic acid. N. Engl.. J. Med., 286, 1–8

    Article  PubMed  CAS  Google Scholar 

  8. Bell, G. D., Whitney, B. and Dowling, R. H. (1972). Gallstone dissolution in man using chenodeoxycholic acid. Lancet, 2, 1213–1216

    Article  PubMed  CAS  Google Scholar 

  9. Makino, I., Hashimoto, H., Shinozaki, K. et al. (1975). Dissolution of cholesterol gallstones by ursodeoxycholic acid. Jap. J. Gastroenterol, 72, 690–702

    CAS  Google Scholar 

  10. Kutz, C. and Schulte, A. (1977). Effectiveness of ursodeoxycholic acid in gallstone dissolution. Gastroenterology, 83, 632–633

    Google Scholar 

  11. Maton, P. M., Murphy, G. M. and Dowling, R. H. (1977). Ursodeoxycholic acid treatment of gallstones. Dose-response study and possible mechanism of action. Lancet, 2, 1297–1301

    Article  PubMed  CAS  Google Scholar 

  12. Doran, J., Keighley, M. R. B. and Bell, G. D. (1979). Rowachol — a possible treatment for cholesterol gallstones! Gut, 20, 312–317

    Article  PubMed  CAS  Google Scholar 

  13. Hofmann, A. F., Thistle, J. L., Klein, P. D. et al. (1978). Chenotherapy for gallstone dissolution. II. Induced changes in bile composition and gallstone response. J. Am. Med. Assoc., 239, 1138–1144

    Article  CAS  Google Scholar 

  14. Salen, G., Nicolau, G. and Shefer, S. (1973). Chenodeoxycholic acid inhibits elevated hepatic HMG-CoA reductase activity in subjects with gallstones. Clin. Res., 21, 523

    Google Scholar 

  15. Coyne, M. J., Bonnoris, G. G., Goldstein, L. I. and Schoenfield, L. J. (1976). Effect of chenodeoxycholic acid and phenobarbital on the rate-limiting enzymes of hepatic cholesterol and bile acid synthesis in patients with gallstones. J. Lab. Clin. Med., 87, 281–291

    PubMed  CAS  Google Scholar 

  16. Northfield, T. C., LaRusso, N. F., Hofmann, A. F. and Thistle, J. L. (1975). Biliary lipid output during three meals and an overnight fast. II. Effect of chenodeoxycholic acid treatment in gallstone subjects. Gut, 16, 12–17

    Article  PubMed  CAS  Google Scholar 

  17. Hardison, W. G. and Grundy, S. M. (1984). Effect of ursodeoxycholate and its taurine conjugate on bile acid synthesis and cholesterol absorption. Gastroenterology, 87, 130–135

    PubMed  CAS  Google Scholar 

  18. Von Bergmann, K., Epple-Gutsfeld, M. and Leiss, O. (1984). Differences in the effects of chenodeoxycholic and ursodeoxycholic acid on biliary lipid secretion and bile acid synthesis in patients with gallstones. Gastroenterology, 87, 136–143

    Google Scholar 

  19. Corrigan, O. I., Su, C., Higuchi, W. and Hofmann, A. F. (1980). Mesophase formation during cholesterol dissolution in ursodeoxycholic-lecithin solutions: new mechanism for gallstone dissolution in humans. J. Pharmaceut. Sci., 69, 869–871

    Article  CAS  Google Scholar 

  20. Ellis, W. R., Bell, G. D. and Clegg, R. J. (1981). Mechanisms for adjuvant cholelitholytic properties of the monoterpene mixture Rowachol. Gastroenterology, 80, 1141

    Google Scholar 

  21. Thistle, J. L. and Hofmann, A. F. (1973). Efficacy and safety of chenodeoxycholic acid for dissolving gallstones. N. Engl. J. Med., 289, 655–659

    Article  PubMed  CAS  Google Scholar 

  22. Bell, G. D., Dowling, R. H., Whitney, B. and Sutor, D. J. (1975). The value of radiology in predicting gallstone type when selecting patients for medical treatment. Gut, 16, 359–364

    Article  PubMed  CAS  Google Scholar 

  23. Wolpers, C. (1976). Auswahl der gallensteintrager zue litholyse. Leber Magen Darm, 6, 43–46

    PubMed  CAS  Google Scholar 

  24. Dolgin, S. M., Schwartz, J. S., Kressel, H. Y. et al (1981). Identification of patients with cholesterol or pigment gallstones by discriminant analysis of radiographic features. N. Engl. J. Med., 304, 808–811

    Google Scholar 

  25. Iser, J. H., Dowling, R. H., Mok, H. Y. I. and Bell, G. D. (1975). Chenodeoxycholic acid treatment of gallstones — a follow-up report and analysis of factors influencing response to therapy. N. Engl. J. Med., 293, 378–383

    Article  PubMed  CAS  Google Scholar 

  26. Maton, P. N., Iser, J. H., Reuben, A. et al (1982). The final outcome of CDCA-treatment in 125 patients with radiolucent gallstones: factors influencing efficacy, withdrawal, symptoms and side effects and post-dissolution recurrence. Medicine, 61, 85–96

    Article  Google Scholar 

  27. Wolpers, C. (1974). Morphologie der gallensteime. Leber Magen Darm, 4, 43–57

    PubMed  CAS  Google Scholar 

  28. Dowling, R. H. (1983). Cholelithiasis: medical treatment. Clin. Gastroenterol, 12, 125–178

    PubMed  CAS  Google Scholar 

  29. Iser, J. H., Maton, P. N., Murphy, G. M. and Dowling, R. H. (1978). Resistance to chenodeoxycholic acid therapy. Treatment in obese patients with gallstones. Br. Med. J., 1, 1509–1512

    Article  PubMed  CAS  Google Scholar 

  30. Dowling, R. H., Ruppin, D. C., Meredith, T., Myszor, M., Forgacs, I. and Murphy, G. M. (1983). Efficacy ofbile acid treatment in dissolving gallstones: colateral benefits of CDCA and UDCA therapy; gallstone recurrence and post-dissolution management. In Paumgartner, G., Stiehl, A. and Gerok, W. (eds.) Bile Acids and Cholesterol in Health and Disease, pp. 345–362. ( Lancaster: MTP Press )

    Google Scholar 

  31. Forgacs, I. C., Maisey, M. N., Murphy, G. M. and Dowling, R. H. (1984). Influence of gallstones and ursodeoxycholic acid therapy on gallbladder emptying. Gastroenterology, 87, 299–307

    PubMed  CAS  Google Scholar 

  32. Ransohoff, D. F. (1985). Natural history of silent gallstones. In Paumgartner, G., Stiehl, A. and Gerok, W. (eds.) Enterohepatic Circulation of Bile Acids and Sterol Metabolism, pp. 277–284. ( Lancaster: MTP Press )

    Google Scholar 

  33. Palmer, A. K. and Heywood, R. (1974). Pathological changes in the rhesus fetus associated with the oral administration of chenodeoxycholic acid. Toxicology, 2, 239–246

    Article  PubMed  CAS  Google Scholar 

  34. Sarva, R. P., Fromm, H., Farivar, S. et al. (1980). Comparison of the effects between ursodeoxycholic and chenodeoxycholic acid on liver function and structure and on bile acid composition in the rhesus monkey. Gastroenterology, 79, 629

    PubMed  CAS  Google Scholar 

  35. Bateson, M. C., Trash, D. B. and Bouchier, I. A. D. (1980). Can a 6-month cholecystogram predict eventual response to gallstone dissolution therapy? Gut, 21, 433 (abstract)

    Article  Google Scholar 

  36. Thomas, P. J. and Hofmann, A. F. (1973). A simple calculation of lithogenic index ofbile. Experimental biliary lipid composition on rectangular coordinates. Gastroenterology, 65, 698–700

    PubMed  CAS  Google Scholar 

  37. Admirand, W. H. and Small, D. M. (1968). The physic-chemical basis of cholesterol gallstone formation in man. J. Clin. Invest., 47, 1045–1052

    Article  Google Scholar 

  38. Hegardt, F. G. and Dam, H. (1971). The solubility of cholesterol in aqueous solution ofbile salts and lecithin. Z. Ernahrungswiss., 10, 223–233

    Article  CAS  Google Scholar 

  39. Holzbach, R. T., Marsh, M., Olszewski, M. and Holan, K. (1973). Cholesterol solubility in bile: evidence that supersaturated bile is frequent in healthy man. J. Clin. Invest., 52, 1467–1479

    Article  PubMed  CAS  Google Scholar 

  40. Kupfer, R. M. and Northfield, T. C. (1983). Diurnal variation in cholesterol saturation of gallbladder bile. Gut, 24, 950–953

    Article  PubMed  CAS  Google Scholar 

  41. Kupfer, R. M., Maudgal, D. P. and Northfield, T. C. (1982). Gallstone dissolution rate during chenic acid therapy. Effect of bedtime administration plus low cholesterol diet. Dig. Dis. Sci., 27, 1025–1029

    Article  PubMed  CAS  Google Scholar 

  42. Somerville, K. W., Rose, D. H., Bell, G. D. et al. (1983). Gallstone dissolution and recurrence: are we being misled? Br. Med. J., 284, 1295–1297

    Article  Google Scholar 

  43. Shapero, T. F., Rosem, I. E., Milson, S. R. and Fisher, M. M. (1982). Discrepancy between ultrasound and oral cholecystography in the assessment of gallstone dissolution. Hepatology, 2, 587–590

    Article  PubMed  CAS  Google Scholar 

  44. Tangedahl, T. (1979). Dissolution of gallstones — when and how? Surg. Clin. N. Am., 59, 797–809

    PubMed  CAS  Google Scholar 

  45. Carey, M. C., Park, Y.-H., Igimi, H. and Salvioli, G. (1985). Factors affecting speed of gallstone dissolution during litholytic therapy. In Paumgartner, G., Stiehl, A. and Gerok, W. (eds.) Enterohepatic Circulation of Bile Acid and Sterol Metabolism. ( Lancaster: MTP Press )

    Google Scholar 

  46. Park, Y.-H., Igimi, H. and Carey, M. C. (1982). The ‘mirroring’ of gallstones: description of a novel silvering method to determine the surface area of an irregular object: in vitro demonstration that multiple gallstones from the same gallbladder dissolve in unsaturated ‘bile’ at the same rato. Gastroenterology, 83, 1071–1088

    PubMed  CAS  Google Scholar 

  47. Maudgal, D. P., Kupfer, R. M. and Northfield, T. C. (1983). Factors affecting gallstone dissolution rate during chenic acid therapy. Gut, 24, 7–10

    Article  PubMed  CAS  Google Scholar 

  48. Northfield, T. C., Lanzini, A., Jazrawi, R., Maudgal, D. P. and Kupfer, R. (1985). Methods of improving the efficacy of litholytic therapy. In Paumgartner, G., Stiehl, A. and Gerok, W. (eds.) Enterohepatic Circulation of Bile Acids and Sterol Metabolism, pp. 335–350. ( Lancaster: MTP Press )

    Google Scholar 

  49. Bell, G. D., Sutor, D. J., Whitney, B. and Dowling, R. H. (1972). Factors influencing human gallstone dissolution in monkey, dog and human bile. Gut, 13, A856

    Google Scholar 

  50. Thistle, J. L., LaRusso, N. F., Hofmann, A. F., Turcottle, J., Carlson, G. L. and Ott, B. J. (1982). Differing effects of ursodeoxycholic or chenodeoxycholic acid on biliary cholesterol saturation and bile acid metabolism in man: a dose response study. Dig. Dis. Sci., 27, 161–168

    Article  PubMed  CAS  Google Scholar 

  51. Carey, M. C. and Ko, G. (1979). The importance of total lipid concentration in determining cholesterol solubility in bile and the development of critical tables for calculating % cholesterol saturation with a correction factor for ursodeoxycholate-rich bile. In Paumgartner, G., Stiehl, A. and Gerok, W. (eds.) Biological Effects of Bile Acids. pp. 299–308. ( Lancaster: MTP Press )

    Google Scholar 

  52. Stiehl, A., Raedsch, R., Czygan, P., Gotz, R., Manner, C. H. and Walker, S. (1980). Effects of biliary bile acid composition on biliary cholesterol saturation in gallstone patients treated with chenodeoxycholic acid and/or ursodeoxycholic acid. Gastroenterology, 79, 1192–1198

    PubMed  CAS  Google Scholar 

  53. Barbara, L., Bazzoli, F., Festi, D., Marselli, A. M. L. and Roda, E. (1983). A comparative study of chenodeoxycholic acid and ursodeoxycholic acid as cholesterol gallstone dissolving agents. In Paumgartner, G., Stiehl, A. and Gerok, W. (eds.) Bile Acids and Cholesterol in Health and Disease, pp. 367–370. ( Lancaster: MTP Press )

    Google Scholar 

  54. Roda, E., Bazzoli, F., Labate, A. M. N., Mazzella, G., Roda, A., Sama, C., Festi, D., Aldini, R., Taroni, F. and Barbara, L. (1982). Ursodeoxycholic acid vs chenodeoxycholic acid as cholesterol gallstone-dissolving agents: a comparative randomised study. Hepatology, 2, 804–810

    Article  PubMed  CAS  Google Scholar 

  55. Erlinger, S., Go, A. L., Hussen, J. M. and Fervery, J. (1984). Franco-Belgium co-operative study of ursodeoxycholic acid in the medical dissolution of gallstones: a double blind randomised, dose-response study, and comparison with chenodeoxycholic acid. Hepatology, 4, 308–314

    Article  PubMed  CAS  Google Scholar 

  56. Fromm, H., Roat, J. N., Gonzalev, V., Sarva, R. J. and Farivar, S. (1983). Comparative efficacy and side effects of ursodeoxycholic acid and chenodeoxycholic acid in dissolving gallstones. Gastroenterology, 85, 1257–1264

    PubMed  CAS  Google Scholar 

  57. Maudgal, D. P., Bird, R. and Northfield, T. C. (1979). Optimal timing of doses of chenic acid in patients with gallstones. Br. Med. J., 1, 922–923

    Article  PubMed  CAS  Google Scholar 

  58. Lanzini, A., Facchinetti, D. and Northfield, T. C. (1984). Therapeutic manipulation of the enterohepatic circulation in cholesterol cholelithiasis. Clin. Sci., 66, 11 P

    Google Scholar 

  59. Maudgal, D. P., Kupfer, R. M. and Northfield, T. C. (1982). Minimum effective dose of chenic acid for gallstone patients: reduction with bedtime administration and a low cholesterol diet. Gut, 23, 280–284

    Article  PubMed  CAS  Google Scholar 

  60. Maudgal, D. P., Bird, R., Blackwood, W. S. and Northfield, T.C. (1978). Low cholesterol diet: enhancement of effect of CDCA in patients with gallstones. Br. Med. J., 2, 851–853

    Article  PubMed  CAS  Google Scholar 

  61. Nilsell, K., Angelin, B., Leijd, B. and Einarsson, K. (1983). Comparative effects of ursodeoxycholic acid and chenodeoxycholic acid on bile and kinetics and biliary lipid secretion in humans. Evidence for different modes of action on bile acid synthesis. Gastroenterology, 85, 1248–1256

    PubMed  CAS  Google Scholar 

  62. Ellis, W. R., Bell, G. D., Middleton, B. and White, D. (1981). Adjunct to bile acid treatment for gallstone dissolution: low dose chenodeoxycholic acid combined with terpene preparation. Br. Med. J., 282, 611–612

    Google Scholar 

  63. Bachrach, W. H. and Hofmann, A. K. (1982). Ursodeoxycholic acid in the treatment of cholesterol cholelithiasis: a review. Dig. Dis. Sci., 27, 833–856

    Article  PubMed  CAS  Google Scholar 

  64. Bateson, M. C., Hopwood, D. and Bouchier, I. A. D. (1977). Effect of gallstone dissolution therapy on human liver structure. Am. J. Dig. Dis., 22, 293–299

    Article  PubMed  CAS  Google Scholar 

  65. Bell, G. D., Mok, H. Y. I., Thwe, M. et al. (1974). Liver structure and function in cholelithiasis: effect of chenodeoxycholic acid. Gut, 15, 165–172

    Article  PubMed  CAS  Google Scholar 

  66. Koch, M. M., Giamperi, M. P., Lorenzini, I. et al. (1980). Effect of chenodeoxycholic acid on liver structure and function in man: a serological and biochemical study. Dig. Dis. Sci., 27, 1025–1029

    Google Scholar 

  67. Carey, J. B., Hoflbauer, F. W., Zaxi, F. G. and Nwokolo, C. (1965). Cholelithiasis and hepatic ductular proliferation induced in rats by lithocholic acid (a bile acid occurring naturally in man). Gastroenterology, 48, 809–810

    Google Scholar 

  68. Palmer, R. H. (1969). Toxic effect of lithocholic acid and related 5-H steroids. In Schiff, L., Carey, J. B. and Dietschy, J. M. (eds.) Bile Salt Metabolism, pp. 184–204. ( Illinois: Springfield )

    Google Scholar 

  69. Low-Beer, T. S., Tyor, M. P. and Lack, L. (1969). Effects of sulfation of taurolithocholic acid and glycolithocholic acids on their intestinal transport. Gastroenterology, 56, 721–725

    CAS  Google Scholar 

  70. Marks, J. W., Sue, S. O., Pearlman, B. J. et al (1981). Sulfation of lithocholate as a possible modifier of chenodeoxycholic acid-induced elevations of serum transaminase in patients with gallstones. J. Clin. Invest., 68, 1190–1196

    Article  CAS  Google Scholar 

  71. Small, D. M. (1971). Gallstone disease — is therapy safe? (Editorial). N. Engl.. J. Med., 284, 214–216

    Article  PubMed  CAS  Google Scholar 

  72. Pedersen, L., Arnfred, T. and Hess-Thaysem, E. (1974). Cholesterol kinetics in patients with cholesterol gallstones before and during chenodeoxycholic acid treatment. Scand. J. Gastroenterol, 9, 787–791

    PubMed  CAS  Google Scholar 

  73. Hoffman, N. E., Hofmann, A. F. and Thistle, J. L. (1974). Effect of bile acid feeding on cholesterol metabolisn in gallstone patients. Mayo Clin. Proc., 49, 236–239

    PubMed  CAS  Google Scholar 

  74. Bell, G. D., Lewis, B., Petrie, A. and Dowling, R. H. (1973). Serum lipids in cholelithiasis: effect of chenodeoxycholic acid therapy. Br. Med. J., 3, 520–523

    Article  PubMed  CAS  Google Scholar 

  75. Bateson, M. C., MacLean, D., Evans, J. R. and Bouchier, I. A. D. (1978). Chenodeoxycholic acid therapy for hypertriglyceridaemia in man. Br. J. Clin. Pharm., 5, 249–254

    CAS  Google Scholar 

  76. Albers, J. I., Grundy, J. M., Clearly, P. A. et al. (1982). For the National Co–operative Gallstone Study Group (NCGS): the effect of chenodeoxycholic acid on lipoproteins and apoproteins. Gastroenterology, 82, 638–646

    PubMed  CAS  Google Scholar 

  77. Angelin, B., Einarsson, K., Hellstrom, K. and Leijd, B. (1978). Effects of cholestyramine and chenodeoxycholic acid on the metabolism of endogenous triglyceride in hyper-lipoproteinaemia. J. Lip. Res., 19, 1017–1024

    CAS  Google Scholar 

  78. Begemann, F. (1978). Influence of chenodeoxycholic acid on the kinetics of endogenous triglyceride transport in man. Eur. J. Clin. Invest., 8, 283–299

    Article  PubMed  CAS  Google Scholar 

  79. Narisawa, T., Sato, T., Hayakawa, M., Sukuma, A. and Nakano, H. (1971). Carcinoma of the colon and rectum and rats by rectal infusion of MNNG. Gut, 62, 231

    CAS  Google Scholar 

  80. Sarwal, A. M., Cohen, B. I. and Raicht, R. F. (1979). Effects of dietary administration of chenodeoxycholic acid on N-methyl-nitrosurea-induced cancer in rats. Biochem. Biophys. Acta., 574, 423

    PubMed  CAS  Google Scholar 

  81. Salvioli, G. and Salati, R. (1979). Faecal bile acid loss and bile acid pool size during short-term treatment with ursodeoxycholic and chenodeoxycholic acid in patients with radiolucent gallstones. Gut, 20, 698

    Article  PubMed  CAS  Google Scholar 

  82. Stiehl, A. (1983). Side-effects of chenodeoxycholic and ursodeoxycholic acid. In Paumgartner, G., Stiehl, A. and Gerok, W. (eds.) Bile Acids and Cholesterol Metabolism in Health and Disease, pp. 387–392. ( Lancaster: MTP Press )

    Google Scholar 

  83. Linos, D. A., Beard, L., O’Fallon, W. M. et al. (1981). Cholecystectomy and carcinoma of the colon. Lancet, 2, 379

    Article  PubMed  CAS  Google Scholar 

  84. Vernick, L. J. and Kuller, L. H. (1971). Cholecystectomy and right-sided colon cancer: an epidemiological study. Lancet, 2, 381

    Google Scholar 

  85. Bateson, M. C., Bouchier, I. A. D., Trash, D. B., Maudgal, D. P. and Northfield, T. C. (1981). Calcification of radiolucent gallstones during treatment with ursodeoxycholic acid. Br. Med. J., 283, 645–6

    Article  CAS  Google Scholar 

  86. Igimi, H. and Carey, M. C. (1980). pH-solubility relation of chenodeoxycholic and ursodeoxycholic acids: physical-chemical basis for dissimilar solution and membrane phenomena. J. Lip. Res., 21, 72–89

    Google Scholar 

  87. Hofmann, A. F. (1985). Secretion and precipitation of calcium in bile. In Paumgartner, G., Stiehl, A. and Gerok, W. (eds.) Enterohepatic Circulation of Bile Acids and Sterol Metabolism. pp. 305–19. ( Lancaster: MTP Press )

    Google Scholar 

  88. Cummings, S. A. and Hoffman, A. F. (1984). Physiological determinants of biliary calcium secretion in the dog. Gastroenterology, 87, 664–73

    PubMed  CAS  Google Scholar 

  89. Dumont, M., Erlinger, S. and Uchman, S. (1980). Hypercholeresis induced by ursodeoxycholic acid and 7-ketolithocholic acid in the rat. Possible role of bicarbonate transport. Gastroenterology, 79, 82–9

    PubMed  CAS  Google Scholar 

  90. Iser, J. H., Murphy, G. M. and Dowling, R. H. (1977). Speed of change in biliary lipids and bile acids with chenodeoxycholic acid — is intermittent therapy feasible? Gut, 18, 7–15

    Article  PubMed  CAS  Google Scholar 

  91. Gleeson, D. and Ruppin, D. C. (1985). Discrepancies between cholecystocraphy and ultrasonography in the detection of recurrent gallstones. J. Hepatol, 1, 597–607

    Article  PubMed  CAS  Google Scholar 

  92. Jazrawi, R. P., Joseph, A. E. A., Wilson, A. G. and Northfield, T. C. (1984). Comparison of cholecystography and ultrasonography for detection of gallstones. Gut, 25, A561

    Google Scholar 

  93. Toulet, J., Rousset, J., Viteau, J. M., Douchon, Y. et al. (1983). Recidives et prevention des recidives apres dissolution de la lithiasis vesiculate par lacide chenodeoxyclique chez 22 patients. Gastroenterol. Clin. Biol, 7, 605

    PubMed  CAS  Google Scholar 

  94. Northfield, T. C., Maudgal, D. P., Kupfer, R. M. and Lanzini, A. (1983). Gallstone dissolution and recurrence. In Paumgartner, G., Stiehl, A. and Gerok, W. (eds.) Bile Acids in Health and Disease, pp. 371–9. ( Lancaster: MTP Press )

    Google Scholar 

  95. Lanzini, A., Jazrawi, R. P., Kupfer, R. M., Maudgal, D. P., Joseph, A. E. A. and Northfield, T. C. (1986). Gallstone recurrence after medical dissolution: an overestimated threat? Hepatology. (In press)

    Google Scholar 

  96. Marks, J. W., Lan, S. and the Steering Committee for the NCGS. (1984). Low dose chenodiol for the prevention of gallstone recurrence following dissolution therapy. Arch. Intern. Med., 100, 976–981

    Google Scholar 

  97. Pomare, E. W., Heaton, K. W., Low-Beer, T. S. and Espiner, H. J. (1976). The effect of wheat bran upon bile salt metabolism and upon the lipid composition of bile in gallstone patients. Am. J. Dig. Dis., 21, 521–526

    Article  PubMed  CAS  Google Scholar 

  98. Thornton, J. R., Emmett, P. M. and Heaton, K. W. (1983). Diet and gallstones: effects of refined and unrefined carbohydrate diets on bile cholesterol saturation and bile acid metabolism. Gut, 24, 2–6

    Article  PubMed  CAS  Google Scholar 

  99. Leuschner, M., Leuschner, U., Strohm, W. D., Trube, E., Fuchs, H. and Classen, M. (1984). Radiological and ultrasonographic investigations with respect to patient selection and monitoring for chemical gallstone dissolution. Hepato-gastroenterology, 31, 140–143

    PubMed  CAS  Google Scholar 

  100. Johansson, G. (1984). A prospective study of the clinical significance of the treatment of gallstones with chenodeoxycholic acid. Surg. Gynaecol. Obstet., 159, 127–129

    CAS  Google Scholar 

  101. Lalloni, L. and the GREPCO Study (1984). Gallbladder ultrasonography as a diagnostic tool in epidemiological screenings. In Capocaccia et al (eds.) Epidemiology and Prevention of Gallstone Disease, pp. 111–115. ( Lancaster: MTP Press )

    Google Scholar 

  102. Ricci, G. (1986). Prevalence of gallbladder disease (The GREPCO and Sirmione studies). Presented at the 9th International Symposium on Bile Acids, Cortina, Italy, March

    Google Scholar 

  103. Glenn, F., McSherry, C. K. and Dineen, P. (1968). The morbidity of surgical treatment for non malignant biliary tract disease. Surg. Gynaecol. Obstet., 126, 15–26

    CAS  Google Scholar 

  104. McSherry, C. K. and Glenn, F. (1980). The incidence and causes of death following surgery for non-malignant biliary tract disease. Ann. Surg., 191, 271–275

    Article  PubMed  CAS  Google Scholar 

Download references

Authors
  1. T. C. Northfield
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. D. P. Maudgal
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. General Hospital, Bishop Auckland, UK

    Malcolm C. Bateson (Consultant Physician and Specialist in Gastroenterology) (Consultant Physician and Specialist in Gastroenterology)

Rights and permissions

Reprints and permissions

Copyright information

© 1986 MTP Press Limited

About this chapter

Cite this chapter

Northfield, T.C., Maudgal, D.P. (1986). Oral Medical Therapy. In: Bateson, M.C. (eds) Gallstone Disease and its Management. Springer, Dordrecht. https://doi.org/10.1007/978-94-009-4173-1_8

Download citation

  • DOI: https://doi.org/10.1007/978-94-009-4173-1_8

  • Publisher Name: Springer, Dordrecht

  • Print ISBN: 978-94-010-8353-9

  • Online ISBN: 978-94-009-4173-1

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation